Lv1
80 积分 2025-05-16 加入
A High-Affinity Antibody-Drug Conjugates Actuximab-MMAE for Potent and Selective Targeting of CEACAM5-Positive Tumors
23天前
已完结
A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
24天前
已完结
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitors
1个月前
已完结
Synergy Assay for Screening Small Molecule Combinations in Brain Cancer Stem Cells
1个月前
已关闭
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy
2个月前
已完结
Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective
2个月前
已完结
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy
2个月前
已完结
Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents
3个月前
已完结
Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)
3个月前
已完结
Insights into recent findings and clinical application of YAP and TAZ in cancer
3个月前
已完结
皖公网安备34019202002308
